133 related articles for article (PubMed ID: 6130077)
1. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
Meltzer HY; Fleming R
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):76-9. PubMed ID: 6130077
[TBL] [Abstract][Full Text] [Related]
2. Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat.
Nash JF; Meltzer HY
J Pharmacol Exp Ther; 1989 Apr; 249(1):236-41. PubMed ID: 2565390
[TBL] [Abstract][Full Text] [Related]
3. The effect of buspirone on prolactin and growth hormone secretion in man.
Meltzer HY; Flemming R; Robertson A
Arch Gen Psychiatry; 1983 Oct; 40(10):1099-102. PubMed ID: 6138009
[TBL] [Abstract][Full Text] [Related]
4. Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover.
Meltzer HY; Simonovic M; Fang VS; Gudelsky GA
Psychopharmacology (Berl); 1982; 78(1):49-53. PubMed ID: 6128756
[TBL] [Abstract][Full Text] [Related]
5. Serum prolactin levels after buspirone in man.
Seppälä T; Ranta T; Shrotriya RC
Med Biol; 1987; 65(1):61-3. PubMed ID: 3613693
[TBL] [Abstract][Full Text] [Related]
6. Effect of yohimbine on rat prolactin secretion.
Meltzer HY; Simonovic M; Gudelsky GA
J Pharmacol Exp Ther; 1983 Jan; 224(1):21-7. PubMed ID: 6294278
[TBL] [Abstract][Full Text] [Related]
7. [Effect of anxiolytics--buspirone and diazepam--on the prolactin, thyrotropin and cortisol content of the blood in the green monkey].
Korneev AIa; Faktor MI; Gliuske EIu
Biull Eksp Biol Med; 1986 Dec; 102(12):726-9. PubMed ID: 2879573
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic control of prolactin secretion in the turkey.
Youngren OM; Pitts GR; Phillips RE; el Halawani ME
Gen Comp Endocrinol; 1996 Nov; 104(2):225-30. PubMed ID: 8930613
[TBL] [Abstract][Full Text] [Related]
9. Buspirone: chemical profile of a new class of anxioselective agents.
Temple DL; Yevich JP; New JS
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):4-10. PubMed ID: 6185470
[TBL] [Abstract][Full Text] [Related]
10. Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.
Geller I; Hartmann RJ
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):25-33. PubMed ID: 6130070
[TBL] [Abstract][Full Text] [Related]
11. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
12. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
[TBL] [Abstract][Full Text] [Related]
13. Prolactin secretion after hypothalamic deafferentation in beef calves: response to haloperidol, alpha-methyl-rho-tyrosine, thyrotropin-releasing hormone and ovariectomy.
Benoit AM; Molina JR; Lkhagvadorj S; Anderson LL
Anim Reprod Sci; 2009 Mar; 111(1):54-68. PubMed ID: 18359173
[TBL] [Abstract][Full Text] [Related]
14. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
[TBL] [Abstract][Full Text] [Related]
16. Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors.
Mulroney SE; Skudlarek C; Shemer A; Lumpkin MD; Kellar KJ
J Pharmacol Exp Ther; 1994 Feb; 268(2):862-7. PubMed ID: 8113999
[TBL] [Abstract][Full Text] [Related]
17. Buspirone hydrochloride: a unique new anxiolytic agent. Pharmacokinetics, clinical pharmacology, abuse potential and clinical efficacy.
Goldberg HL
Pharmacotherapy; 1984; 4(6):315-24. PubMed ID: 6151170
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
Jagannathan V; Venitz J
Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
[TBL] [Abstract][Full Text] [Related]
20. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
Tresguerres JA; Esquifino AI
Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
